Glucocorticoids in Patients With IgG4-RD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a randomized, open-label, single-center clinical trial to compare the efficacy and safety profile for medium-dose versus high dose glucocorticoid in patients with IgG4-related Disease. Patients will be followed for three months to measure the primary outcome and secondary outcomes.
Epistemonikos ID: 7f1dc4e04814b8885acd47934bb98e6834d484f4
First added on: May 11, 2024